EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE. (2023). International Research Journal of Pharmacy, 14(11), 21-25. https://doi.org/10.56802/kedfgd52